Quick Answer
Cordyceps Sunshine Biotech Holdings Co., Ltd. reported R&D Expense of $118.4 thousand for fiscal year 2022.
Cordyceps Sunshine Biotech Holdings Co., Ltd. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2022 | $118.4K | +372.8% |
| 2021 | $25.1K | — |
- Cordyceps Sunshine Biotech Holdings Co., Ltd. showed an increase of +372.8% in R&D Expense compared to the prior fiscal year.
- Over the 2021–2022 period, Cordyceps Sunshine Biotech Holdings Co., Ltd.’s r&d expense has grown by 372.8% (from $25.1 thousand to $118.4 thousand).
- The most recent figure is from Cordyceps Sunshine Biotech Holdings Co., Ltd.’s fiscal year 2024 report (Form 20-F), filed with the SEC on June 13, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: